$XMTR

Altschuler Randolph sold $534K of XMTR

Altschuler Randolph sold 5,722 shares of Xometry, Inc. (XMTR) at an average of $93.30 ($90.96–$96.89, $0.53M total) across 6 trades on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Altschuler Randolph
Published Jul 6, 2026, 9:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
high confidence
Mentioned
$XMTR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

This adds incremental transparency on insider activity but does not introduce new fundamentals (no earnings, guidance, contracts, litigation, or regulatory actions).

02

Market read

Traders may monitor insider activity for sentiment/flow optics, but the 10b5-1 structure and lack of new fundamentals keep the trading signal weak.

03

What to watch

The disclosure does not indicate whether sales were part of a broader planned cadence, nor does it provide context on total insider holdings changes beyond the post-transaction figure.

Relevance 4/10Novelty 3/10Timing: Filed July 6 after July 2 insider sale disclosure becomes public.

Background

The article is an SEC Form 4 insider transaction: director Altschuler Randolph sold 5,722 XMTR shares across six trades on July 2 under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$XMTRNeutralHigh confidence
Context

Xometry director Altschuler Randolph sold $533,869 of XMTR shares via an open-market sale under a 10b5-1 plan on July 2.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be short-lived around sentiment/flow optics.

Evidence & confidence

The filing is a director open-market sale with a pre-arranged 10b5-1 plan; no new company-specific operational or guidance information is provided.

Market effects

Minimal—this is company-specific insider transaction disclosure with no sector-wide regulatory or demand signal.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated director selling can be interpreted by some traders as confidence/valuation-driven liquidity needs, potentially pressuring short-term sentiment.

Key entities

  • Xometry, Inc.

    Company whose shares were sold; Form 4 reports the director’s open-market sale details.

  • Altschuler Randolph

    Director who executed the sale; filing reports trade dates, share counts, and weighted-average price.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.